Caprelsa
vandetanib
Thyroid Neoplasms
Date of authorisation:
Revision: 52
Last updated:
MedicineHumanAuthorised
Maci - referral
matrix applied characterised autologous cultured chondrocytes
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Maci
matrix-applied characterised autologous cultured chondrocytes
Fractures, Cartilage
Date of authorisation:
Date of refusal:
Revision: 4
Last updated:
MedicineHumanExpired
EMEA-000979-PIP01-10-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0012/2018
Route(s) of administration: Implant use
Pharmaceutical form(s):
Implant
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000052-PIP01-07-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0285/2013
Route(s) of administration: Oral use
Pharmaceutical form(s):
Tablet
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Zactima
vandetanib
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application